SMITHKLINE BEECHAM LIMITED
Company Information
- Company Number
- 02337959
- Registered Address
- 980 Great West Road, Brentford, Middlesex, TW8 9GS
- Status
- Active
- Employee Count
- 563.0
- Turnover
- 121000000.0
- EBITDA
- 23000000.0
Additional Details
- Website
- https://gsk.com
- Company Type
- Private limited Company
- Incorporated On
- 24 January 1989
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products$64209 - Activities of other holding companies not elsewhere classified
- Industries
- 0
- Region
- London
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 64 | 19% | 20% | 61% | 4% |
| 01 Jan 2023 - 30 Jun 2023 | 28 Jul 2023 | 63 | 22% | 18% | 60% | 5% |
| 01 Jul 2022 - 31 Dec 2022 | 27 Jan 2023 | 67 | 18% | 14% | 68% | 10% |
| 01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 65 | 21% | 14% | 65% | 8% |
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 62 | 24% | 16% | 60% | 7% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 66 | 21% | 15% | 65% | 11% |
| 01 Jul 2020 - 31 Dec 2020 | 28 Jan 2021 | 61 | 28% | 15% | 57% | 6% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 65 | 23% | 14% | 63% | 7% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 63 | 25% | 16% | 59% | 11% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 62 | 16% | 42% | 41% | 18% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 71 | 8% | 40% | 52% | 19% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 74 | 6% | 14% | 80% | 32% |
Company Summary
SmithKline Beecham Limited is a British pharmaceutical company that specializes in the research, development, and production of innovative medicines and healthcare products
The company was founded in 1999 through the merger of SmithKline Beecham and Glaxo Wellcome
It is now a part of the global healthcare company GlaxoSmithKline
The company's sustainability program is focused on reducing its environmental impact and promoting responsible business practices
This includes efforts to reduce carbon emissions, decrease water usage, and increase recycling
SmithKline Beecham Limited also works to ensure the safety and ethical sourcing of its ingredients and materials
SmithKline Beecham Limited offers a wide range of products and services in various therapeutic areas such as respiratory, oncology, immunology, and vaccines
Some of their well-known products include Sensodyne toothpaste, Panadol pain relief, and Nicorette smoking cessation products
The key people at SmithKline Beecham Limited include CEO Emma Walmsley and Chairman Jonathan Symonds
They lead a team of dedicated scientists, researchers, and employees who are committed to improving the health and well-being of people around the world
For more information on SmithKline Beecham Limited, including their sustainability efforts and products, visit their website at www.gsk.com
The registered office address for the company is 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Company Review
Trend Analysis
The trend for SMITHKLINE BEECHAM LIMITED is that the average time taken to pay invoices has been decreasing over the past three periods. There was a significant decrease from 2018 to 2021, with a slight increase in 2022 and then a decrease again in 2023.
Volatility Analysis
The volatility for SMITHKLINE BEECHAM LIMITED has been relatively stable over the past three periods, with the highest volatility occurring in 2018 and the lowest in 2019.
Summary Analysis
From 2018 to 2023, the average time taken for SMITHKLINE BEECHAM LIMITED to pay invoices has decreased from 74 days to 64 days. This is a 13.5% decrease over the three periods.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Qualifying contracts for this entity contain a number of different payment periods: Immediate 30 days 60 days 45 days 30 days and 5th of the following month 60 days and 5th of the following month Payments are made from date of receipt of invoice.
Were there any changes to the standard payment terms in the reporting period?
Yes – Standard 30-day terms for SMEs were introduced in place of a previous offer of 30 day terms upon application by the vendor.
Any other information about payment terms
1) Statistics Reported: Intercompany invoices and performance have been excluded from reported statistics as these are generally wholly owned group companies and would distort performance if included. 2) Payment terms for SMEs and 'Paid on Time' monitoring: Preferential payment terms of 30 days are put in place for vendors that are confirmed as SMEs (Small and Medium Enterprises). We closely monitor our KPIs on a weekly basis to ensure that vendors (including SMEs) are paid on time. Corrective actions are taken to remedy any late payment issues where these are within the entity’s control.
Maximum contractual payment period agreed
60
Dispute Resolution Process
We offer our suppliers the following support and service: Enquiries and complaints can be logged through our Helpdesk support system (mail or telephone). Issues are often related to incorrect invoice submission, payment terms are not as per contract, PO details are wrong / nonexistent etc. Key performance metrics are monitored for quality of Helpdesk support. Our Supplier web pages also include details and a link to our Speak Up channels that enable concerns to be raised, including channels managed independently of GSK and the option to do so anonymously, although naturally it helps in resolving matters if we know as much as possible about the issue and complainant. We have invested in Customer Relationship Management (CRM) to ensure effective and independent supplier follow up and support to our suppliers raising issues.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
✅
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
